DEA Blames The Media For Making It Harder To Arrest People Over Weed

Submitted ~ means of Carey Wedler via TheAntiMedia.org,

According to the DEA, the riddle with cannabis in the United States isn’t that it’s appease designated a dangerous drug with no medicinal value in spite of volumes of emerging philosophical research indicating otherwise.

The problem is actually that the media has made it perplexing for government agents to arrest family for selling and consuming it. The DEA moreover blames the increasing trend of legalization athwart the United States. In its 2016 National Drug Threat Assessment Summary [pdf], the DEA observes that “While marijuana leavings illegal under federal law, many states be in possession of passed laws allowing the cultivation, state of being possessed, and use of marijuana within their several states.”

The agency then argues:

“Due to these varying commonwealth laws, as well as an exuberance of media attention surrounding claims of feasible medical benefits, the general public has been introduced to repugnant and often inaccurate information regarding the legality and benefits of marijuana use.”

As a proceed, they contend: “This has made compulsion and prosecution for marijuana-related offenses greater degree of difficult, especially in states that wish approved marijuana legalization.

Indeed, the DEA is amend in asserting an increasing number of individuals in states thwart the country have opted to suppress barriers to cannabis use. From California to Colorado and Oregon to Washington D.C., 28 states acquire legalized either medical or recreational practice.

But the agency’s wording that “~y abundance of media attention surrounding claims of in posse medical benefits” actually reveals the disingenuousness of its comments. Though the DEA frames the healing qualities of cannabis as doubtful, using indefinite terms like “claims” and “feasible,” its own policies prove its statements “opposite.”

In 2015, the DEA itself requested increased amounts of cannabis to be used for research to determine whether or not the set in the ground can be used to treat freedom from disease conditions. Though this does not necessarily prove there are benefits, it shows unruffled the nation’s “authority” ~ward drugs is adapting to the reinvigorated era of ending cannabis prohibition and can no longer blindly deny the plant’s potential.

Still, in spite of its limited efforts to confess cannabis for research purposes, a study published in the pry-reviewed PLOS Biology journal highlighted the barriers powers that be drug policies’ pose to research:

“In the United States, incorporated town and state governments often move to marauder novel drugs before the federal guidance believes it has sufficient evidence to constrain that determination. Some have been most distant in their lack of understanding of pharmacology.”

This represents a self-repeating aperture whereby government policy restricts research, and the DEA at that time implies research is insufficient to verify medical benefits.

Regardless, though the DEA unwavering to keep cannabis a harmful “Schedule 1” physic in August, other branches of the body of executive officers might disagree with its assessment. According to www.cancer.gov, a website advance by the National Institute for Cancer, cannabis holds great number potential benefits for treating nausea, vomiting, distress, anxiety, and loss of appetite.

While, again, “potential” is a key qualifier, the corresponding; of like kind fact sheet acknowledges that “Two cannabinoids (dronabinol and nabilone) are drugs approved ~ means of the U.S. Food and Drug Administration (FDA) in spite of the prevention or treatment of chemotherapy-akin nausea and vomiting.” The same page notes “[a]nother active cannabinoid is cannabidiol (CBD), that may relieve pain, lower inflammation, and curtail anxiety.”

If we are to accept the authority of the DEA being of the cl~s who a federal agency, we must likewise accept the authority of the FDA. But it appears the DEA’s claims in regard to “claims” regarding marijuana are contrary in the face of other regulation organizations’ opinions, as well as the opinions of therapeutic experts who condemn drug war management.

In another example, the United States guidance has held a patent on marijuana towards its antioxidant properties since 1979.

Still, the DEA blames the media because of highlighting the benefits of marijuana, in like manner as many stories about the possible benefits of cannabis are rooted in ongoing discoveries made through philosophical research — a factor the DEA fails to hold in remembrance in its criticism of the media.

Further, plane absent any scientific data on the plant, anecdotal evidence of cannabis shows accurate how much it is helping folks in need. These are not “claims,” since the DEA suggests.

A recent video of a forgoing cop with debilitating Parkinson’s ail showed how just a few drops of cannabis oil helped assuage his uncontrolled movements and relieve his suffering, and available medical research backs up his continued. Epileptic children enjoy relief from exact seizures, and preliminary medical research too supports their experiences. Countless cancer patients affirm to the immense benefits cannabis brings them, especially whenever it comes to mitigating the personal estate of chemotherapy. One man who suffered from staggering collect together headaches as a result of the nation’s biggest in the course of nature gas leak in history found alleviation from cannabidiol (CBD) oil after severe numerous other treatments with no good luck. Of his experience, endocannabinoid researcher, Dr. Saoirse O’Sullivan of the University of Nottingham’s of medicine school, observed:

“The thing approximately CBD is that because it has in such a manner many facets, so many ways in what one. it acts, that probably, the rejoinder was a combination of a slender bit of all of them. [It was ] in all probability not just one thing — and that’s which makes it such a rich mix with ~s.”

Just last night, the creator of this article was suffering from a migraine for a like rea~n severe she couldn’t keep victuals down, yet with a few drops of non-psychoactive CBD oil, the penalty and nausea disappeared.

Instead of blaming states and media outlets — and ~ dint of. extension, academic researchers — for evolving bygone time the drug war mentality, the DEA would effect well to examine its own practices.

Is it in posse people are beginning to see the irrationality of sending men with guns to powerfully arrest individuals who consume an old plant humans have used for thousands of years? Could it subsist that people are finally beginning to pay attention the cracks in decades of propaganda in anticipation of cannabis?

Though more research is undoubtedly needed to decide the exact medical benefits of marijuana, the identical argument could be made for dangerous pharmaceutical drugs approved by the FDA based ~ward research conducted by their manufacturers. As the FDA notes, “It is the accountableness of the company seeking to emporium a drug to test it and submit evidence that it is safe and cogent.”

While it’s important not to sketch the plant as a cure-total for any ailment — and careful search that finds drawbacks of marijuana exercise must also be further investigated — the DEA’s comments forward cannabis do little more than affirm that its policies are outdated, its mentality is increasingly ancient, and that it’s digging its heels into the aging, disallowance paradigm, even as the rest of the geographical division moves on.

Because getting treatment not beyond one hour of a heart charge increases the survival rate, experts decide not to ignore intense chest fret that lasts for more than five minutes.

Both comments and pings are currently closed.